Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rescigno

Showing results (611-620 of 1,117) with videos related to

Pageof 112
Sort By:
Nature Immunology|August 28, 2024
NaCl enhances CD8<sup>+</sup> T cell effector functions in cancer immunotherapyCaterina Scirgolea, Rosa Sottile, Marco De Luca, et al.
Frontiers in Immunology|August 15, 2022
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countriesMaria Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, et al.
Prostate Cancer and Prostatic Diseases|January 7, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 studyThomas Büttner, Mimma Rizzo, Laura Bernal Vaca, et al.
Journal of the National Cancer Institute|December 29, 2020
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation CarriersJulika Borde, Corinna Ernst, Barbara Wappenschmidt, et al.
Frontiers in Immunology|July 22, 2024
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 studyMartina Catalano, Sara Elena Rebuzzi, Marco Maruzzo, et al.
JAMA Network Open|November 27, 2023
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving NivolumabMartina Catalano, Sara Elena Rebuzzi, Marco Maruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
The Journal of Clinical Investigation|December 25, 2019
Genomics of lethal prostate cancer at diagnosis and castration resistanceJoaquin Mateo, George Seed, Claudia Bertan, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
European Urology|May 1, 2019
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate CancerAdam Sharp, Jon C Welti, Maryou B K Lambros, et al.
Pageof 112

Showing results (611-620 of 1,117) with videos related to

Sort By:
Pageof 112
Nature Immunology|August 28, 2024
NaCl enhances CD8<sup>+</sup> T cell effector functions in cancer immunotherapyCaterina Scirgolea, Rosa Sottile, Marco De Luca, et al.
Frontiers in Immunology|August 15, 2022
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countriesMaria Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, et al.
Prostate Cancer and Prostatic Diseases|January 7, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 studyThomas Büttner, Mimma Rizzo, Laura Bernal Vaca, et al.
Journal of the National Cancer Institute|December 29, 2020
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation CarriersJulika Borde, Corinna Ernst, Barbara Wappenschmidt, et al.
Frontiers in Immunology|July 22, 2024
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 studyMartina Catalano, Sara Elena Rebuzzi, Marco Maruzzo, et al.
JAMA Network Open|November 27, 2023
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving NivolumabMartina Catalano, Sara Elena Rebuzzi, Marco Maruzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
The Journal of Clinical Investigation|December 25, 2019
Genomics of lethal prostate cancer at diagnosis and castration resistanceJoaquin Mateo, George Seed, Claudia Bertan, et al.
Cancer Discovery|April 29, 2017
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP InhibitionJane Goodall, Joaquin Mateo, Wei Yuan, et al.
European Urology|May 1, 2019
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate CancerAdam Sharp, Jon C Welti, Maryou B K Lambros, et al.
Pageof 112